Chemoinformaics analysis of 15-Hydroxy-20-deoxyvinblastine
| Molecular Weight | 810.989 | nRot | 7 |
| Heavy Atom Molecular Weight | 752.525 | nRig | 3 |
| Exact Molecular Weight | 810.42 | nRing | 9 |
| Solubility: LogS | -7.865 | nHRing | 6 |
| Solubility: LogP | 17.349 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 117 | No. of Aliphatic Hetero Cycles | 5 |
| No. of Heavy Atom | 59 | No. of Aromatic Carbocycles | 2 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 46 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 16 |
| nHA | 12 | APOL | 127.112 |
| nHD | 3 | BPOL | 73.434 |
| QED | 0.035 |
| Synth | 2.554 |
| Natural Product Likeliness | 0.232 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.003 |
| CACO-2 | -5.342 |
| MDCK | 0.000000521 |
| BBB | 0 |
| PPB | 1.05317 |
| VDSS | 3.807 |
| FU | 0.00382917 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.086 |
| CYP2c19-inh | 0.059 |
| CYP2c19-sub | 0.028 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.982 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.001 |
| CYP3a4-inh | 0.099 |
| CYP3a4-sub | 0.006 |
| CL | 4.4 |
| T12 | 0.012 |
| hERG | 0.291 |
| Ames | 0.006 |
| ROA | 0.003 |
| SkinSen | 0.992 |
| Carcinogencity | 0.026 |
| EI | 0.911 |
| Respiratory | 0.28 |
| NR-Aromatase | 0.025 |
| Antiviral | Yes |
| Prediction | 0.902209 |